1. Propranolol as a potentially novel treatment of arteriovenous malformations
- Author
-
Jian Huang, Jinwei Wang, Jianyun Lu, Jinhua Huang, Zhaoqi Yin, Radean T. Anvari, Yaping Xiang, Jing Chen, Shiyao Pei, Wenbin Tan, and J. Stuart Nelson
- Subjects
MAPK/ERK pathway ,arteriovenous malformation ,p-AKT ,phosphorylated extracellular signal-regulated kinases ,Dermatology ,Propranolol ,030204 cardiovascular system & hematology ,Pharmacology ,phosphorylated protein kinase B ,p-S6K ,Article ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,phosphorylated ribosomal s6 kinase ,p-ERK ,lcsh:Dermatology ,Medicine ,phosphorylated c-Jun N-terminal protein kinases ,propranolol ,AVM, arteriovenous malformation ,p-PI3K ,p-JNK, phosphorylated c-Jun N-terminal protein kinases ,business.industry ,lcsh:RL1-803 ,AVM ,MAPK ,p-JNK ,p-S6K, phosphorylated ribosomal s6 kinase ,p-PI3K, phosphorylated phosphatidylinositol 3-kinases ,p-ERK, phosphorylated extracellular signal-regulated kinases ,MAPK, mitogen-activated protein kinases ,mitogen-activated protein kinases ,phosphorylated phosphatidylinositol 3-kinases ,business ,p-AKT, phosphorylated protein kinase B ,medicine.drug - Abstract
Author(s): Lu, Jianyun; Anvari, Radean; Wang, Jinwei; Huang, Jian; Pei, Shiyao; Xiang, Yaping; Huang, Jinhua; Yin, Zhaoqi; Chen, Jing; Nelson, J Stuart; Tan, Wenbin
- Published
- 2018
- Full Text
- View/download PDF